Studies have found that higher doses can further reduce glycosylated hemoglobin and body weight, and the safety is similar to low doses
Food choices, protein intake, activity level, sleep, stress, and dose progression all affect results
130 For example, a popular dual agonist, tirzepatide (brand name Mounjaro), activates both GLP-1 and GIPR
Long term, after three or more months on a stable dose, most people have minimal side effects
Meanwhile, WeightWatchers offers compounded semaglutide starting at $129 a month
Additionally, blockade of GLP-1Rs in the LS with exendin-9 alone enhanced sucrose and oil intake indicating a physiologic role for these neurons to suppress food intake